Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
Crossref DOI link: https://doi.org/10.1007/s40264-016-0464-3
Published Online: 2016-10-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Raschi, Emanuel
Bianchin, Matteo
Ageno, Walter
De Ponti, Roberto
De Ponti, Fabrizio
Funding for this research was provided by:
Authors at the University of Bologna are supported by Institutional Research Funds (Ricerca Fondamentale Orientata).
License valid from 2016-10-01